Skip to main content
. Author manuscript; available in PMC: 2009 Feb 2.
Published in final edited form as: Magn Reson Imaging. 2006 Nov 21;25(1):1–13. doi: 10.1016/j.mri.2006.09.006

Fig. 3.

Fig. 3

Pretreatment (top row) and post-treatment (bottom row) 3D volume renderings of each parameter’s assessment of the tumor extent of a representative patient (different from that displayed in Fig. 2) are presented. Each volume is rendered at 50% of each respective parameter’s maximum value obtained from the pretreatment study (i.e., only those voxels with values >50% of the maximum pretreatment value are displayed). Comparing the top row to the bottom row, the T1, Ktrans and νe maps indicated a tremendous drop in the extent of disease, while the τi map presents some residual areas of elevated τi. It is important to note that the T1, Ktrans and νe maps still have voxel values that are elevated above healthy values, but they are no longer above 50% of the maximum value obtained from the pretreatment study. Post-treatment ADC rendering shows an increase in overall ADC when compared to pretreatment rendering.